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The article by Agarwal et al. (1) published in Translational 
Andrology and Urology at the end of the past year, faces 
the important topic of the clinical utility of sperm DNA 
fragmentation (SDF) test. 
Currently, a great debate is present in the literature 
regarding the possible routine use of SDF within male and 
couple infertility work up. The article by Agarwal et al. (1), 
besides reviewing the different methods that can be used 
to detect SDF, has the merit to provide clinical indications 
for some medical scenarios where the SDF tests may have 
relevance (summarized in the Table 2 of Agarwal’s paper). 
The most important problem emerging from the current 
debate in the literature regarding the clinical utility of 
SDF tests is the presence of several possible assays which 
are very different both in the procedure and in the type 
of damage they are detecting. Regarding these points, the 
article by Agarwal et al. (1) reports the main advantages and 
disadvantages of the different techniques used to detect 
SDF in Table 1 of Agarwal’s paper. The issue of the type 
of damage revealed by the different techniques is very 
important and deserves a deeper investigation. Keeping in 
mind that the most important damage is the one impacting 
the reproductive outcomes, it is important to define better 
the relationship between the used test and the considered 
outcomes. This point has been faced in recent meta-
analyses (2-5) where studies were grouped according to 
the methods. Interestingly, when the miscarriage rate is 
considered as endpoint both after assisted reproductive 
techniques (ARTs) and natural pregnancies, the terminal 
deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) method appears to be the most predictive, 
followed by sperm chromatin structure assay (SCSA) (2). 
Similar results were obtained in the meta-analysis by 
Osman et al. (4) where the considered endpoint was live 
birth rate after ARTs and where TUNEL was again the 
most predictive technique followed by single cell gel 
electrophoresis assay (COMET). According to this meta-
analysis, when intracytoplasmic sperm injection (ICSI) was 
employed to perform ART, none of the tests was predictive 
of clinical pregnancy (4). In the meta-analysis performed 
by Cissen et al. (3), where clinical pregnancy after in vitro 
fertilization (IVF) and ICSI was considered as endpoint, 
only TUNEL and COMET showed a “fair” predictive 
value, whereas SCSA and sperm chromatin dispersion 
test (SCD) tests showed a “poor” prediction. Finally, 
the recent meta-analysis by Simon et al. (5) reports that 
TUNEL, COMET and SCD were predictive of clinical 
pregnancy after IVF and ICSI. Although the included 
studies in these meta-analyses are different, and female 
factor is neglected in most studies, all appear to agree on 
the fact that SCSA and SCD techniques are, respectively, 
not or poorly predictive of ARTs outcomes. The scenario 
appears different in studies on natural reproduction (6) and 
intrauterine insemination (IUI) (7), where SCSA technique 
results were found to be a good predictor of pregnancy. 
This result was confirmed in a recent study by Ribas-
Maynou et al. (8) where also COMET, TUNEL and SCD 
were predictive of natural pregnancy. Overall, these studies 
confirm that the different techniques detect different types 
of damage. This conclusion is supported also by studies 
investigating the effect of sperm selection techniques on 
DNA integrity. It has been recently shown that the density 
gradient centrifugation (DGC) technique provokes an 
increase of DNA damage in highly motile selected sperm 
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(9,10). However, at variance with TUNEL, such increase 
does not appear to be detected by SCSA (9). Further studies 
will be necessary to understand whether also COMET and 
SCD are able to detect DNA damage after DGC. It must be 
considered that most studies evaluating SDF before and after 
DGC selection report the average pre- and post-DGC SDF 
values, possibly masking effects present in single samples (10). 
Post-selection DNA damage could highly affect outcomes 
of ART (10).
A n o t h e r  i m p o r t a n t  c o n s e q u e n c e  o f  l a c k  o f 
standardization and heterogeneity of the SDF detecting 
assays is that several threshold values have been proposed to 
discriminate pathological and normal conditions. This fact 
contributes to create confusion regarding the introduction 
of SDF tests in the diagnostic management of infertile men. 
Hopefully, a committee shall be soon organized to decide 
which is the gold standard method to evaluate SDF in the 
couple infertility work-up.
In the review by Agarwal et al.  (1), the authors 
discussed the paper by Esteves et al. (11) which described 
a subpopulation of sperm with massive nuclear SDF, the 
so called “degraded sperm”, which is overrepresented in 
varicocele patients. These authors suggested that patients 
with varicocele could be identified by the sole examination 
of semen specimens, provided the differentiation of sperm 
with fragmented and degraded DNA was performed. These 
data suggest that besides the type of damage detected, 
SDF tests should have the ability to focus on the clinically 
relevant sperm population. Our group has recently 
demonstrated that a cytometric sperm subpopulation [the so 
called “brighter sperm” (12)] is a better predictor of natural 
pregnancy (13). Similarly, focusing on the viable sperm 
fraction (14) is expected to retain higher clinical value as 
only viable spermatozoa participate in the fertilization 
process. Along the same line, it is expected that sperm 
selected for ARTs should be the clinically relevant sperm 
subpopulation for prediction of outcomes: evaluating SDF 
in the fraction used for oocyte fertilization should result 
indeed in higher prediction. However, whether SDF in 
selected sperm is more predictive of ARTs respect to neat 
semen is currently controversial (10,15,16).
Regarding the interesting point of clinical indications 
raised by the review of Agarwal et al. (1), it should be 
mentioned that, in addition to the clinical scenarios 
considered by the authors in Table 2 of the paper, 
emerging data in the literature suggest that other 
conditions may benefit from using SDF as diagnostic tool, 
including men with advanced age (17), diabetes (18,19), 
presence of inflammatory signs of the lower genital 
tract (20) and cancer (21-23). Concerning this latter 
condition, it has to be considered that both the presence 
of malignancy (as part of the paraneoplastic syndrome (24) 
and the chemo-radio therapies (23) required to treat 
cancer, affect DNA integrity of germ cells. 
An important question that the clinicians face in case 
of a patient with high SDF levels is what to do next. 
Among the possible strategies, the clinician may choose 
to treat the patient to restore sperm DNA integrity, or to 
select the most appropriate ART treatment. Considering 
that testicular apoptosis and oxidative stress are the main 
mechanisms generating SDF (25,26), compounds able 
to target these two mechanisms are possible useful tools. 
Although some studies using antioxidants reported a 
positive effect in reducing SDF levels (27-29), no clear 
conclusions can be drawn about their effectiveness on 
reproduction outcome because these studies show several 
limitations (30). Similarly, although follicle stimulating 
hormone (FSH) has been used to target testicular apoptosis 
in several studies, whether the hormone is effective in 
reducing SDF levels remain to be defined because of the 
presence of non-responding subjects (31-35). The strategy 
based on selection of patients according to the FSH 
receptor (FSHR) genotype before treatment proposed by 
Simoni et al. (35) appears to be promising. In case of ART 
treatment, an issue often neglected by clinicians concerns 
the iatrogenic induction of DNA damage during in vitro 
sperm manipulation (9,10,36). Indeed, it is well known 
that SDF may proceed after ejaculation during in vitro 
incubations similar to those used to fertilize the oocyte by 
IVF (37-39).
In conclusion, on the road to introduce SDF in the male 
infertility work-up, more studies are needed addressing 
three important points: (I) establishing the gold standard 
technique for each reproductive outcome; (II) finding 
effective pharmacological treatments to decrease sperm 
DNA damage in vivo; (III) establishing correct strategies to 
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